Skip to content

CapEx at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.05B+31.9%
Amgen logo
AmgenAMGN
$712M+73.2%
Exelixis logo
ExelixisEXEL
$1.51M-48.9%
AbbVie logo
AbbVieABBV
$265M+12.8%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$91K+153%
Nuvation Bio logo
Nuvation BioNUVB
$48K-33.3%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$942.78M+86.2%
Enterprise value$927.97M+95.5%
P/S13.2×+3.9×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's capex?
Kura Oncology (KURA) reported capex of $128K in Q1 2026.
How has Kura Oncology's capex changed year-over-year?
Kura Oncology's capex decreased by 56.2% year-over-year, from $292K to $128K.
What is the long-term trend for Kura Oncology's capex?
Over 4 years (2021 to 2025), Kura Oncology's capex has grown at a 55.1% compound annual growth rate (CAGR), from $1.15M to $6.64M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.